BCR-ABL1-IN-1 is a highly potent, orally bioavailable inhibitor with remarkable specificity towards ABL kinase, showing significant promise for elucidating the precise role of ABL kinases in the central nervous system, particularly in preclinical investigations [1].
Molecular Weight:
359.3
CAS Number:
[1488090-21-6]
Formula:
C18H12F3N3O2
Target:
Others|||Bcr-Abl
T61324
* VAT and and shipping costs not included. Errors and price changes excepted
